A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models is a research paper published in Cell Proliferation (2021). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Natural Science Foundation of China
Grant: 81500054
National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China
Grant: 2018ZX09711001-011
National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China
Grant: 2019ZX09201001
The Clinical Research Innovation Project, West China Hospital, Sichuan University
Grant: 2019HXCX05
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
FWCI
2.61
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals